↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Gianinazzi M) "

Sökning: WFRF:(Gianinazzi M)

Resultat 1-3 av 3

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Andiman, W, et al. (författare) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies 1999 Ingår i: The New England journal of medicine. - 0028-4793. ; 340:13, s. 977-987 Tidskriftsartikel (refereegranskat)
2.	Aebi, C, et al. (författare) Combination antiretroviral therapy and duration of pregnancy 2000 Ingår i: AIDS (London, England). - : Ovid Technologies (Wolters Kluwer Health). - 0269-9370. ; 14:18, s. 2913-2920 Tidskriftsartikel (refereegranskat)
3.	Acosta, C., et al. (författare) Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden 2021 Ingår i: Journal of Medical Economics. - : Informa UK Limited. - 1369-6998 .- 1941-837X. ; 24:1, s. 770-780 Tidskriftsartikel (refereegranskat)abstract Aims: To evaluate the cost-effectiveness of adding prolonged-release (PR)-fampridine to best supportive care (BSC) versus BSC alone for the improvement of walking ability in patients with MS. Methods: A cost-utility analysis based on a Markov model was developed to model responders and timed 25-foot walk (T25FW) scores, accumulated costs, and quality-adjusted life-years (QALY) in adults with MS and Expanded Disability Status Scale (EDSS) scores between 4 and 7. The analysis was conducted from a Swedish societal perspective. Results: In the base-case analysis, PR-fampridine plus BSC led to a higher QALY gain than BSC alone. The largest direct cost was professional care provision followed by hospital inpatient stays while the indirect cost was the loss of earnings due to days off work. The incremental cost-effectiveness ratio (ICER) for PR-fampridine plus BSC compared with BSC alone was 57,109 Swedish Kronor (kr)/QALY (€5,607/QALY [1 kr = €0.0981762 on 8 April 2021] and $6,675/QALY [1 kr = $0.116890 on 8 April 2021]). All sensitivity analyses performed resulted in ICERs below 500,000 kr (€49,088 and $58,445). Limitations: Resource use data were not specific to the Swedish market. Conclusions: PR-fampridine represents a cost-effective treatment for MS-related walking impairment in Sweden, due to improvements in patients’ quality of life and reduced healthcare resource utilization. © 2021 Biogen International GmbH. Published by Informa UK Limited, trading as Taylor & Francis Group.

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-3 av 3

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (3)

Typ av innehåll: refereegranskat (3)

Författare/redaktör: Giaquinto, C (2); Mur, A (2); de Jose, I (2); Grosch-Worner, I (2); Nadal, D (2); Wyler, CA (2); visa fler...; Kind, C (2); Rudin, C (2); Cheseaux, JJ (2); Aebi, C (2); De Maria, A (2); De Rossi, A (2); Levy, J (2); Duse, M (2); Scherpbier, H (2); Mok, J (2); Perrin, L (2); Gianinazzi, M. (2); Biedermann, K (2); Drack, G (2); Erb, P (2); Hosli, I (2); Irion, O (2); Lauper, U (2); Schreyer, A (2); Schupbach, J (2); Ruga, E (2); Schafer, A (2); Johnstone, F (2); Bates, I (2); Hawkins, F (2); Asensi-Botet, F (2); Perez-Tamarit, D (2); Boer, K (2); Lindgren, S (2); Ehrnst, A (2); Belfrage, E (2); Barlow, P (2); Ferrazin, A (2); Gotta, C (2); Paya, A (2); Coll, O (2); Fortuny, C (2); Boguna, J (2); Caro, MC (2); Canet, Y (2); Pardi, G (2); Ravizza, M (2); Guerra, B (2); Lanari, M (2); visa färre...

Lärosäte: Karolinska Institutet (2); Göteborgs universitet (1)

Språk: Engelska (3)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy